000			01721 a2200433 4500
005			20250516055706.0
264		0	_c20120402
008			201204s 0 0 eng d
022			_a1468-2060
024	7		_a10.1136/ard.2011.154211 _2doi
040			_aNLM _beng _cNLM
100	1		_aGrabiec, Aleksander M
245	0	0	_aHistone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. _h[electronic resource]
260			_bAnnals of the rheumatic diseases _cMar 2012
300			_a424-31 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntirheumatic Agents _xadministration & dosage
650	0	4	_aArthritis, Rheumatoid _xmetabolism
650	0	4	_aCells, Cultured
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFibroblasts _xdrug effects
650	0	4	_aHistone Deacetylase Inhibitors _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aHydroxamic Acids _xadministration & dosage
650	0	4	_aInflammation Mediators _xmetabolism
650	0	4	_aInterleukin-6 _xbiosynthesis
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aNF-kappa B _xphysiology
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSynovial Membrane _xdrug effects
650	0	4	_aTranscription Factor AP-1 _xmetabolism
700	1		_aKorchynskyi, Olexandr
700	1		_aTak, Paul P
700	1		_aReedquist, Kris A
773	0		_tAnnals of the rheumatic diseases _gvol. 71 _gno. 3 _gp. 424-31
856	4	0	_uhttps://doi.org/10.1136/ard.2011.154211 _zAvailable from publisher's website
999			_c21190413 _d21190413